In Latin America, biofarma access to the public system is blocked without approved diagnostics. Chimera solves that. We create next-gen diagnostics using multi-epitope recombinant proteins engineered to accelerate regulatory approval, unlocking the SUS and LATAM public markets for global biofarma. We’re not just diagnostics. We’re the biotech chimera: one platform, multiple market unlocks.
Company Details
- Founded
- -
- Address
- Divinópolis, Br
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://linktr.ee/chimerabio
- Keywords
- Innovative Biotech Products, R&D in Biotechnology, Biotech Consultancy, Advanced Biotech Solutions, Bio-production, Bioprocessing, Scientific Research, Protein Therapeutics, Bioengineering, Immunology Applications, Health and Life Sciences, Custom Protein Solutions, Molecular Biology Solutions, Protein Engineering, Biotechnology Innovation, Biopharmaceutical Research, Multi-Epitope Proteins, Recombinant Proteins.
- HQ
- Divinópolis
- Competitors
- Biozeus Biopharmaceutical S.A., FAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas Gerais, ASAMMPLAY CORPORATE, Lavigne HPV Solutions, Easy Termo, GRITE - Group of Technological Innovation and Entrepreneurship, BioPractical Film, Executive Classes, LACOG - Latin American Cooperative Oncology Group, FAPDF.
Chimera Questions
Chimera's website is https://linktr.ee/chimerabio
Chimera's LinkedIn profile is https://br.linkedin.com/company/chimerabio
Chimera's industry is
Biotechnology Research
Chimera's top competitors are
Biozeus Biopharmaceutical S.a.,
Fapemig - Fundação De Amparo À Pesquisa Do Estado De Minas Gerais,
Asammplay Corporate,
Lavigne Hpv Solutions,
Easy Termo,
Grite - Group Of Technological Innovation And Entrepreneurship,
Biopractical Film,
Executive Classes,
Lacog - Latin American Cooperative Oncology Group,
Fapdf.
Chimera's categories are Biotechnology Research
Chimera's founding year is 2023
